Showing results (1-10 of 560) with videos related to
Sort By:
Pageof 56
Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2024
PNPLA3 variation and kidney diseaseAlessandro Mantovani, Giovanni TargherAnnals of Translational Medicine|August 1, 2017
Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver diseaseAlessandro Mantovani, Giovanni TargherClinics in Geriatric Medicine|June 27, 2020
Nonalcoholic Fatty Liver Disease and Implications for Older Adults with DiabetesAlessandro Mantovani, Giovanni Targher, Giacomo ZoppiniCurrent Heart Failure Reports|July 4, 2023
Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart FailureRiccardo M Inciardi, Alessandro Mantovani, Giovanni TargherThe Lancet. Gastroenterology & Hepatology|January 9, 2023
Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver diseaseGiovanni Targher, Alessandro Mantovani, Christopher D ByrneThe Lancet. Gastroenterology & Hepatology|January 14, 2022
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic reviewAlessandro Mantovani, Christopher D Byrne, Giovanni TargherAnnals of Hepatology|May 1, 2020
Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesityAmedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, et al.Digestive Diseases and Sciences|January 27, 2016
Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver DiseaseAlessandro Mantovani, Stefano Ballestri, Amedeo Lonardo, et al.International Journal of Molecular Sciences|February 11, 2016
Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?Alessandro Mantovani, Paolo Gisondi, Amedeo Lonardo, et al.Journal of Hepatology|November 11, 2017
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?Amedeo Lonardo, Fabio Nascimbeni, Alessandro Mantovani, et al.Pageof 56